Completed PHASE4 INTERVENTIONAL 4-arm NCT00006170

Bupropion and Weight Control for Smoking Cessation - 1

Bupropion and Weight Control for Smoking Cessation

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Bupropion Placebo smoking cessation intervention weight concerns intervention

Updated 7 times since 2017 Last updated: Jun 22, 2016 Started: Sep 30, 2000 Primary completion: Dec 31, 2009 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00006170, this PHASE4 trial focuses on Tobacco Use Disorder and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 7 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States